Bausch Health Companies Inc.
BHC CA0717341071
Bausch Health Companies Inc. is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch Lomb, a supplier of eye health products. Bausch Healths business model is primarily focused on acquiring small pharmaceutical companies and then sharply increasing the prices of the drugs these companies sell.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 29% | -77% | 28% | 4% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Carson Seana EX VP |
7.31 USD |
13,370 Sold |
97,735 USD |
05/09/2025 | 08/09/2025 |
| Lee Frank D. |
7.66 USD |
15,912 Sold |
121,886 USD |
21/08/2025 | 21/08/2025 |
| Paulson John |
9.00 USD |
34,721,118 Bought |
312,490,062 USD |
14/08/2025 | 14/08/2025 |
| Paulson John |
7.06 USD |
86,409 Bought |
610,048 USD |
11/08/2025 | 13/08/2025 |
| Paulson John |
6.88 USD |
1,156,640 Bought |
7,957,683 USD |
11/08/2025 | 12/08/2025 |
| Paulson John |
6.35 USD |
2,000,000 Bought |
12,700,000 USD |
11/08/2025 | 11/08/2025 |
| Paulson John |
5.94 USD |
3,564,059 Bought |
21,170,510 USD |
13/06/2025 | 13/06/2025 |
| Paulson John |
5.47 USD |
1,005,376 Bought |
5,499,407 USD |
10/06/2025 | 12/06/2025 |
| Paulson John |
5.24 USD |
1,029,098 Bought |
5,392,474 USD |
10/06/2025 | 11/06/2025 |
| Paulson John |
5.05 USD |
754,134 Bought |
3,808,377 USD |
10/06/2025 | 10/06/2025 |